Complications of Acute Ischaemic Stroke
- 5 March 1998
- journal article
- research article
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 8 (2), 124-132
- https://doi.org/10.1159/000015830
Abstract
Neurological, cardiac, and systemic complications during the first days to weeks after ischaemic stroke can cause substantial morbidity and mortality. The reported 30-day case fatality rate for cerebral infarction varies between 10 and 17%. The incidence and effects of the various complications vary with time after stroke: transtentorial herniation and other cerebral complications prevail during the 1st week, whereas medical complications are more prominent in the weeks thereafter. Many complications are treatable, and some are preventable. The goal of this report is to provide information on their incidence, consequences, and management.Keywords
This publication has 8 references indexed in Scilit:
- CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic strokeThe Lancet, 1997
- The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic strokeThe Lancet, 1997
- Thrombolytic Therapy with Streptokinase in Acute Ischemic StrokeNew England Journal of Medicine, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic strokeThe Lancet, 1995
- Effect of blood pressure and diabetes on stroke in progressionThe Lancet, 1994
- Do stroke units save lives?The Lancet, 1993
- Cardiac arrhythmias in patients with acute cerebrovascular accidentsJAMA, 1981